|
|
Volumn 72, Issue 2, 2015, Pages 90-
|
|
Blinatumomab approved for rare leukemia
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLINATUMOMAB;
DEXAMETHASONE;
ANTINEOPLASTIC AGENT;
BISPECIFIC ANTIBODY;
ACUTE LYMPHOBLASTIC LEUKEMIA;
CANCER CHEMOTHERAPY;
CONSTIPATION;
DRUG APPROVAL;
DRUG INDUCED HEADACHE;
FEBRILE NEUTROPENIA;
FEVER;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HYPOKALEMIA;
NAUSEA;
NOTE;
PERIPHERAL EDEMA;
PHARMACIST;
PHILADELPHIA CHROMOSOME NEGATIVE PRECURSOR B CELL ACUTE LYMPHOBLASTIC LEUKEMIA;
PRIORITY JOURNAL;
RASH;
RECOMMENDED DRUG DOSE;
TREMOR;
DRUG INDUSTRY;
LEGISLATION AND JURISPRUDENCE;
LEUKEMIA;
UNITED STATES;
ANTIBODIES, BISPECIFIC;
ANTINEOPLASTIC AGENTS;
DRUG APPROVAL;
DRUG INDUSTRY;
HUMANS;
LEUKEMIA;
UNITED STATES;
|
|
EID: 84930167685
PISSN: 10792082
EISSN: 15352900
Source Type: Journal
DOI: 10.2146/news150005 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|